Condition: Acute Myeloid Leukemia · Accelerated Phase Chronic Myeloid Leukemia · Blast Phase Chronic Myeloid Leukemia · Sponsor: Incyte Biosciences International Sàrl
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and efficacy of ponatinib in children aged 1 to \< 18 years with advanced leukemias, lymphomas, and solid tumors.
This description comes directly from the study's public registry record.
Incyte Corporation Call Center (ex-US) · +800 00027423 · globalmedinfo@incyte.com
Always discuss trial participation with your own doctor first.
| Ghent University Hospital | Ghent, Belgium | Recruiting |
| Hopital Robert Debre | Paris, France | Recruiting |
| Armand Trousseau Hospital | Paris, France | Recruiting |
| Centre Hospitalier Universitaire de Poitiers | Poitiers, France | Recruiting |
| Chu de Rennes - Hospital Sud | Rennes, France | Completed |
| Aou Policlinico S. Orsola-Malpighi | Bologna, Italy | Recruiting |
| Asst Degli Spedali Civili Di Brescia | Brescia, Italy | Recruiting |
| Ospedale Pediatrico G. Gaslini | Genova, Italy | Recruiting |
| Comitato Etico Fondazione Irccs Istituto Nazionale Dei Tumori Milano | Milan, Italy | Recruiting |
| University of Milano Bicocca | Monza, Italy | Recruiting |
| Aorn Santobono Pausilipon | Naples, Italy | Not Yet Recruiting |
| Comitato Di Bioetica Della Fondazione Irccs Policlinico San Matteo | Pavia, Italy | Recruiting |
+ 11 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03934372